#27 – Reinventing neuroelectronic therapies – Carolina Aguilar – Inbrain Neuroelectronics

Impulse – Meeting Healthcare Pioneers

#27 – Reinventing neuroelectronic therapies – Carolina Aguilar – Inbrain Neuroelectronics

April 7, 2024

#27 – Reinventing neuroelectronic therapies – Carolina Aguilar – Inbrain Neuroelectronics

We are at a turning point for brain-computer interfaces (BCIs) and neurotechnology.

We have all witnessed phenomenal progress in this field recently via images shared by Neuralink, showing paralyzed patients who can communicate with a computer through their own thoughts. Other fascinating applications, such as those being worked on by Gregoire Courtine and Jocelyne Bloch, enable paraplegics to regain an unprecedented degree of walking mobility.

These advancements are mind-blowing and illustrate the potential of these technologies to address conditions that have a major impact on quality of life.

What if we were to enhance the physical properties of these implants while making them more accessible in terms of costs to health systems? Where could this paradigm shift take us, and what prospects could it open up for treating complex neurological disorders?

This is what we explore in this episode with Carolina Aguilar, CEO of Inbrain Neuroelectronics, a company developing a cutting-edge neural platform based on graphene, promising to change the way we decode, modulate, and stimulate neuronal activity.

We talk with Carolina about:

  • How Inbrain Neuroelectronics’ technology enhances the resolution of BCIs and their therapeutic potential
  • The stakes around BCIs and their promise in treating serious neurological disorders
  • The importance of focusing their development around therapeutic indications vs. aiming for human augmentation
  • The commercialization of these solutions through a value-based care approach and key success factors
  • Empowering women in science and business

An outlook on the future of brain therapies that bridges the gap between reality and science fiction!


(00:03:22) – Explaining Inbrain Neuroelectronics’ neural platform

(00:07:32) – The medical need for BCIs and the first indications targeted by Inbrain Neuroelectronics

(00:18:46) – Risks around BCIs and ethical considerations for the field to head in the right direction

(00:26:17) – Toward value-based commercial models for BCIs

(00:29:40) – Transitioning from Medtronic to an early-stage Medtech startup

(00:33:29) – Empowering women in science and business

What we also talked about with Carolina:

We cited with Carolina some of the past episodes from the series:

As mentioned by Carolina during the episode, you can access Inbrain Neuroelectronics’ publications here and learn more about their ongoing research and therapy development efforts. You can listen to the Neurotech Pub podcast hosted by Matt Angle here.

Feel free to follow Inbrain Neuroelectronics activities on LinkedIn.

If you want to contact Carolina, you can reach out to her over LinkedIn.

If you want to give me feedback on the episode or suggest potential guests, contact me over LinkedIn or via email at [email protected]!

If you liked the episode, please share it, subscribe to the podcast, and leave a 5-star review on streaming platforms! 🙏

There’s now a monthly newsletter around the podcast where you will be informed of the latest episodes and updated on the latest medical tech progress, subscribe here!

Lastly, don’t forget to follow our activities on LinkedIn and our website!

Listen on your favorite player

New to Podcasts? It's easy to get started!

You may also like

Top Health Podcasts. Delivered to Your Inbox and Eardrums.

Join Our Newsletter

We gratefully acknowledge the many organizations that have generously supported our podcasts and platform.

Network Sponsors and Advertisers

Event and Media Partners

Buffer LinkedIn WhatsApp